TruAlt Bioenergy Ltd

Net profit of TruAlt Bioenergy declined 46.39% to Rs 59.88 crore in the quarter ended March 2026 as against Rs 111.69 crore during the previous quarter ended March 2025. Sales declined 34.34% to Rs 595.52 crore in the quarter ended March 2026 as against Rs 906.99 crore during the previous quarter ended March 2025. For the full year,net profit declined 34.57% to Rs 95.95 crore in the year ended March 2026 as against Rs 146.64 crore during the previous year ended March 2025. Sales declined 9.45% to Rs 1727.51 crore in the year ended March 2026 as against Rs 1907.72 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales595.52906.99 -34 1727.511907.72 -9 OPM %19.9416.95 -16.7716.21 - PBDT106.65128.41 -17 216.18226.34 -4 PBT83.70110.90 -25 129.95159.44 -18 NP59.88111.69 -46 95.95146.64 -35 Powered by Capital Market - Live

TruAlt Bioenergy will hold a meeting of the Board of Directors of the Company on 22 May 2026.

TruAlt Bioenergy today announced a strategic investment of Rs 13 crore by GAIL (India) in its subsidiary, Leafiniti Bioenergy (LBPL), marking a significant step in advancing its Compressed Biogas (CBG) portfolio and strengthening its role in India's energy transition. This investment is pursuant to the Share Subscription-cum-Shareholders' Agreement executed on 11 August  2025, under which GAIL is set to acquire 49% equity stake in Leafiniti. Under the terms of the agreement, GAIL will invest an aggregate amount of Rs 13,54,32,150 (Rs 13 crore) towards subscription of equity shares in Leafiniti, with the capital to be deployed towards new CBG projects. Post completion of the transaction, TruAlt will retain a stake of 51%, while GAIL will hold 49% equity, reflecting a balanced and strategic partnership structure. The investment is aligned with defined project approvals and governance mechanisms, ensuring disciplined capital allocation and phased scale-up of the clean gas portfolio. The collaboration represents a significant milestone in India's clean energy roadmap, combining TruAlt's expertise in bioenergy production with GAIL's extensive gas infrastructure and market reach. The joint venture will focus on establishing multiple greenfield CBG plants across Karnataka, Maharashtra, and Odisha, as part of a phased rollout designed to scale rapidly and deliver measurable environmental, economic, and social impact. In its first phase, the joint venture will roll out six state-of-the-art greenfield plants, each with a capacity of 12 tonnes per day, primarily based on associated residues from sugar mills, delivering a combined annual output of 23,976 tonnes of CBG. This buildout is expected to create approximately 820 to 1,225 direct and indirect jobs, catalysing rural employment and economic activity. In addition to clean energy, the facilities will generate high-value agricultural inputs, including 97,902 tonnes of Fermented Organic Manure (FOM) and 4,70,862 tonnes of Liquid Fermented Organic Manure (LFOM) annually. This will improve soil health and strengthen circular agriculture, ensuring that farmers become active stakeholders and beneficiaries in India's green energy transition. From an environmental perspective, the JV's first phase is projected to displace approximately 19,800 tonnes of fossil fuels annually and avoid 9,300 tonnes of methane emissions per annum, contributing meaningfully to India's climate commitments, including its net-zero by 2070 vision. Powered by Capital Market - Live

TruAlt Bioenergy will hold a meeting of the Board of Directors of the Company on 3 February 2026.Powered by Capital Market - Live

TruAlt Bioenergy has signed a non-binding Memorandum of Understanding (MoU) with the Andhra Pradesh Economic Development Board (APEDB), the Government of Andhra Pradesh's nodal agency for the establishment of a Sustainable Aviation Fuel (SAF) production plant in the State of Andhra Pradesh. The proposed project is envisaged to involve a total investment of approximately Rs 2,250 crore, to be developed in phases, subject to detailed feasibility assessments, technology evaluation, and confirmation of commercial viability. Powered by Capital Market - Live

Net Loss of TruAlt Bioenergy reported to Rs 37.94 crore in the quarter ended September 2025 as against net loss of Rs 18.66 crore during the previous quarter ended September 2024. Sales declined 70.41% to Rs 114.86 crore in the quarter ended September 2025 as against Rs 388.22 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales114.86388.22 -70 OPM %-3.964.45 - PBDT-28.39-0.17 -16600 PBT-49.18-16.26 -202 NP-37.94-18.66 -103 Powered by Capital Market - Live

TruAlt Bioenergy will hold a meeting of the Board of Directors of the Company on 11 November 2025.Powered by Capital Market - Live

TruAlt Bioenergy will hold a meeting of the Board of Directors of the Company on 19 October 2025.Powered by Capital Market - Live